Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Total 13F shares
-
2,207,792
-
Share change
-
-191,307
-
Total reported value
-
$4,170,727
-
Put/Call ratio
-
20%
-
Price per share
-
$1.89
-
Number of holders
-
20
-
Value change
-
-$310,715
-
Number of buys
-
4
-
Number of sells
-
11
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q3 2023
As of 30 Sep 2023,
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,207,792 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, STATE STREET CORP, and TWO SIGMA INVESTMENTS, LP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.